Eads & Heald Wealth Management Amgen Inc Transaction History

Eads & Heald Wealth Management

$206 Million
Q2 2024

A detailed history of Eads & Heald Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Eads & Heald Wealth Management holds 8,695 shares of AMGN stock, worth $2.76 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

8,695

Previous 8,737 0.48%

Holding current value

$2.76 Million

Previous $2.48 Million 9.34%

% of portfolio

1.32%

Previous 1.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$262.75 - $319.31 $11,035 - $13,411	-42 Reduced 0.48%	8,695 $2.72 Million
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $147,609 - $178,183	-549 Reduced 5.91%	8,737 $2.48 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $35,542 - $40,095	-139 Reduced 1.47%	9,286 $2.67 Million
Q3 2023 Oct 27, 2023	SELL	$218.65 - $271.46 $21,646 - $26,874	-99 Reduced 1.04%	9,425 $2.53 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $92,993 - $109,962	-434 Reduced 4.36%	9,524 $2.11 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $67,511 - $82,284	299 Added 3.1%	9,958 $2.41 Million
Q4 2022 Jan 27, 2023	SELL	$229.03 - $291.01 $8,474 - $10,767	-37 Reduced 0.38%	9,659 $2.54 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $9,651 - $10,885	43 Added 0.45%	9,696 $2.19 Million
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $26,070 - $29,011	-113 Reduced 1.16%	9,653 $2.35 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $10,744 - $11,885	-49 Reduced 0.5%	9,766 $2.36 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $45,543 - $52,120	229 Added 2.39%	9,815 $2.21 Million
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $57,949 - $67,895	273 Added 2.93%	9,586 $2.04 Million
Q2 2021 Jul 30, 2021	SELL	$233.58 - $259.14 $22,190 - $24,618	-95 Reduced 1.01%	9,313 $2.27 Million
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $7,988 - $9,309	-36 Reduced 0.38%	9,408 $2.34 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $8,006 - $9,533	37 Added 0.39%	9,444 $2.17 Million
Q3 2020 Nov 02, 2020	SELL	$234.65 - $260.95 $170,825 - $189,971	-728 Reduced 7.18%	9,407 $2.39 Million
Q2 2020 Jul 29, 2020	SELL	$197.81 - $242.74 $34,814 - $42,722	-176 Reduced 1.71%	10,135 $2.39 Million
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $102,236 - $135,593	-561 Reduced 5.16%	10,311 $2.09 Million
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $58,844 - $75,635	-311 Reduced 2.78%	10,872 $2.62 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $17,236 - $20,653	99 Added 0.89%	11,183 $2.16 Million
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $5,334 - $6,253	-32 Reduced 0.29%	11,084 $0
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $542 - $611	3 Added 0.03%	11,116 $0
Q4 2018 Jan 31, 2019	SELL	$178.4 - $208.25 $22,656 - $26,447	-127 Reduced 1.13%	11,113 $2.16 Million
Q3 2018 Oct 31, 2018	BUY	$185.29 - $208.89 $3,891 - $4,386	21 Added 0.19%	11,240 $0
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $11,125 - $12,496	67 Added 0.6%	11,219 $0
Q1 2018 Apr 26, 2018	SELL	$169.43 - $198.0 $55,911 - $65,340	-330 Reduced 2.87%	11,152 $0
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $1,856 - $2,074	-11 Reduced 0.1%	11,482 $0
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $1.92 Million - $2.2 Million	11,493	11,493 $0

Others Institutions Holding AMGN

# of Institutions

3,056

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.

Account

Eads & Heald Wealth Management Amgen Inc Transaction History